 |
|
Press Releases
Experts Present Therapeutic Strategies for Hepatitis B & C FOSTER CITY, CA--(Marketwire), 17 March 2008 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to host a symposium at the 18th annual meeting of the Asian Pacific Association for the Study of the Liver (APASL), in Seoul, Korea on Tuesday, March 25, 2008. The symposium, "Therapeutic Strategies for Hepatitis B & C - Treatment Regimens Using Thymosin a-1, an Immunomodulator," will take place on March 25, 2008, from 3:00 to 4:00 p.m. local time, at the COEX Convention Center in Seoul, Korea. Experts in the field of liver disease will discuss ZADAXIN®, generically referred to as thymalfasin or thymosin alpha 1, and its therapeutic benefits as a treatment for hepatitis B and hepatitis C. -- Yun-Fan Liaw, M.D., Professor of Medicine in the Liver Research Unit at Chang Gung University and Memorial Hospital in Taipei, Taiwan, will discuss ZADAXIN as an immunomodulatory treatment for patients infected with the hepatitis B virus. -- Mario Rizzetto, M.D., Professor of Gastroenterology at San Giovanni Battista Hospital of the University of Torino in Torino, Italy, and the Principal Investigator for a nearly completed phase 3 hepatitis C triple therapy trial in Europe, will follow with a presentation on the use of triple therapy (pegylated interferon, ribavirin and thymalfasin) in the treatment of hepatitis C non-responder patients. -- Kyusung Rim, MD, the 2007 congress chairman for the Korean Association for the Study of the Liver will serve as the meeting chairman and moderator. "APASL is an important forum that provides the most current, innovative and advanced therapeutic technologies to prominent physicians specializing in the treatment of liver disease in Asia," commented Hans P. Schmid, President and Managing Director of SciClone Pharmaceuticals International Limited. "We are pleased to have respected experts such as Drs. Liaw and Rizzetto present thymalfasin's efficacy and safety data in the treatment of patients infected with the hepatitis B and hepatitis C viruses." About SciClone: SciClone Pharmaceuticals is a biopharmaceutical company engaged in the development of therapeutics to treat life-threatening diseases. SciClone's lead product ZADAXIN is currently being evaluated in late-stage clinical trials for the treatment of hepatitis C and malignant melanoma. ZADAXIN is approved for sale in select markets internationally, most notably in China where SciClone has an established sales and marketing operation. A key part of SciClone's strategy is to leverage its advantage and broaden its portfolio in the rapidly growing Chinese pharmaceutical market by in-licensing or acquiring the marketing rights to other products, such as DC Bead™. For the U.S. market, SciClone's other clinical-stage drug development candidates are RP101 for the treatment of pancreatic cancer and SCV-07 for the treatment of hepatitis C. For more information about SciClone, visit http://www.sciclone.com. Media Contacts: Corporate Contact: Richard Waldron Executive Vice President & Chief Financial Officer SciClone Pharmaceuticals, Inc. (650) 358-3437 Footnotes: M170o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr Note To Editors: M170o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr Disclaimer: M170o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr Submitted by Asia Release on Monday, 17 March 2008 at 6:30 PM Category: Health Care & Medical |
|
|
 |
|
Scoopasia v1.0b. Copyright © 2008
Today is Monday, 8 September 2008 |
Want to get your press releases, event listings, and job ads on Scoopasia? 
| Journalist's Toolbox |  |
|
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!
(Instant Information Request) The easiest way to ask questions and request information from the PR community. Drill down, dig deep, for media information the way you want it. Resources and tools you can't do without. | |
| PR Tools |
|
Scoopasia Blog Search
Search the largest handpicked collection of Asia's most prominent and influential blogs. |
| Resources |
|
More Coming Soon... |
